Sequence Name |
Description |
Length |
Blast Hits |
min E-value |
Similarity |
GO hits |
GO names |
Enzyme Codes |
InterPro Scan |
contig01801 |
20s rrna homolog |
590 |
20 |
2.60E-63 |
62.25% |
2 |
C:nucleolus; P:ribosome assembly |
|
|
contig01802 |
mitochondrial translational release factor 1 |
719 |
20 |
1.49E-89 |
83.85% |
3 |
F:translation release factor activity; P:regulation of translational termination; C:mitochondrion |
|
|
contig01803 |
squamous cell carcinoma antigen recognized by t cells |
582 |
20 |
1.48E-63 |
96.55% |
7 |
C:cytosol; P:cell cycle arrest; P:positive regulation of cytotoxic T cell differentiation; P:RNA splicing; P:induction of apoptosis by intracellular signals; C:spliceosomal complex; P:mRNA processing |
|
|
contig01804 |
transcription factor dp-1 |
806 |
20 |
5.59E-78 |
85.00% |
10 |
P:S phase of mitotic cell cycle; P:regulation of transcription from RNA polymerase II promoter; P:apoptosis; C:transcription factor complex; P:epidermis development; F:transcription factor activity; P:transcription antitermination; F:transcription coactivator activity; P:positive regulation of transcription, DNA-dependent; P:cell proliferation |
|
|
contig01805 |
---NA--- |
244 |
0 |
|
|
0 |
|
|
|
contig01806 |
---NA--- |
283 |
0 |
|
|
0 |
|
|
|
contig01807 |
exosome component 9 |
281 |
20 |
1.50E-38 |
93.10% |
7 |
C:cytoplasm; C:nucleolus; F:3'-5'-exoribonuclease activity; F:RNA binding; F:protein binding; P:rRNA processing; C:exosome (RNase complex) |
|
|
contig01808 |
---NA--- |
246 |
0 |
|
|
0 |
|
|
|
contig01809 |
---NA--- |
223 |
0 |
|
|
0 |
|
|
|
contig01810 |
delta-aminolevulinic acid dehydratase |
699 |
20 |
2.02E-120 |
90.05% |
3 |
P:heme biosynthetic process; F:porphobilinogen synthase activity; F:zinc ion binding |
EC:4.2.1.24 |
|
contig01811 |
---NA--- |
832 |
0 |
|
|
0 |
|
|
|
contig01812 |
---NA--- |
395 |
0 |
|
|
0 |
|
|
|
contig01813 |
ribosomal protein s17 |
810 |
20 |
1.65E-69 |
98.00% |
4 |
F:structural constituent of ribosome; F:RNA binding; C:cytosolic small ribosomal subunit; P:translation |
EC:3.6.5.3 |
|
contig01814 |
---NA--- |
1123 |
0 |
|
|
0 |
|
|
|
contig01815 |
rae1 rna export 1 homolog ( pombe) |
257 |
20 |
1.26E-04 |
99.85% |
9 |
C:nuclear pore; C:nuclear outer membrane; C:nucleus; C:cytoplasm; F:RNA binding; P:mRNA export from nucleus; F:protein binding; F:microtubule binding; C:cytoskeleton |
|
|
contig01816 |
suppressor of ty 5 homolog |
253 |
20 |
5.10E-38 |
96.90% |
12 |
P:cell cycle; P:positive regulation of transcription from RNA polymerase II promoter; P:retroviral genome replication; F:enzyme binding; P:negative regulation of transcription from RNA polymerase II promoter; F:positive transcription elongation factor activity; F:negative transcription elongation factor activity; P:RNA elongation from RNA polymerase II promoter; F:protein heterodimerization activity; P:chromatin remodeling; C:nucleus; P:response to organic substance |
|
|
contig01817 |
---NA--- |
529 |
0 |
|
|
0 |
|
|
|
contig01818 |
chromosome 14 open reading frame 169 |
567 |
20 |
1.65E-39 |
67.35% |
4 |
P:ribosome biogenesis; F:RNA binding; P:chromatin remodeling; C:nucleolar preribosome |
|
|
contig01819 |
---NA--- |
525 |
0 |
|
|
0 |
|
|
|
contig01820 |
---NA--- |
651 |
0 |
|
|
0 |
|
|
|
contig01821 |
origin recognition subunit 1-like |
293 |
20 |
6.59E-38 |
91.00% |
6 |
P:DNA replication; F:DNA binding; F:protein binding; F:ATP binding; F:nucleoside-triphosphatase activity; C:nucleus |
EC:3.6.1.15 |
|
contig01822 |
member ras oncogene family |
418 |
20 |
1.74E-46 |
97.05% |
8 |
F:GTP binding; C:Golgi apparatus; C:plasma membrane; F:ATP binding; P:intracellular protein transport; F:transcription factor binding; P:small GTPase mediated signal transduction; P:regulation of transcription, DNA-dependent |
|
|
contig01823 |
importin 7 |
254 |
20 |
2.00E-42 |
84.15% |
5 |
C:cytoplasm; C:nuclear pore; P:protein import into nucleus, docking; F:histone binding; F:protein transporter activity |
|
|
contig01824 |
topoisomerase i |
517 |
20 |
1.89E-36 |
89.65% |
13 |
C:cytoplasm; C:nucleolus; F:DNA topoisomerase type I activity; C:nucleoplasm; P:response to drug; F:DNA topoisomerase (ATP-hydrolyzing) activity; F:protein binding; C:perikaryon; P:embryonic cleavage; P:DNA unwinding involved in replication; F:chromatin DNA binding; C:chromosome; P:DNA topological change |
EC:5.99.1.2; EC:5.99.1.3 |
|
contig01825 |
---NA--- |
290 |
0 |
|
|
0 |
|
|
|
contig01826 |
---NA--- |
104 |
0 |
|
|
0 |
|
|
|
contig01827 |
---NA--- |
263 |
0 |
|
|
0 |
|
|
|
contig01828 |
histidine triad protein member 5 |
285 |
20 |
2.44E-40 |
84.35% |
6 |
C:cytoplasm; F:protein binding; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; F:hydrolase activity; C:nucleus; P:deadenylation-dependent decapping of nuclear-transcribed mRNA |
|
|
contig01829 |
cold shock domain-containing protein e1 |
470 |
20 |
4.39E-42 |
89.50% |
4 |
C:mitochondrial inner membrane; F:DNA binding; F:RNA binding; P:regulation of transcription, DNA-dependent |
|
|
contig01830 |
narg2 protein |
742 |
20 |
9.12E-37 |
72.35% |
1 |
C:nucleus |
|
|
contig01831 |
zinc cchc domain containing 10 |
1141 |
20 |
5.51E-28 |
94.85% |
2 |
F:zinc ion binding; F:nucleic acid binding |
|
|
contig01832 |
---NA--- |
248 |
0 |
|
|
0 |
|
|
|
contig01833 |
syntaxin 12 |
302 |
20 |
2.84E-33 |
94.10% |
9 |
C:phagocytic vesicle; F:SNAP receptor activity; C:Golgi apparatus; P:cholesterol efflux; C:membrane raft; P:vesicle-mediated transport; P:intracellular protein transport; P:protein stabilization; C:integral to membrane |
|
|
contig01834 |
---NA--- |
251 |
0 |
|
|
0 |
|
|
|
contig01835 |
chmp member 7 |
611 |
20 |
1.43E-33 |
83.40% |
2 |
P:protein transport; C:cytoplasm |
|
|
contig01836 |
ethylmalonic encephalopathy 1 |
339 |
20 |
3.22E-13 |
81.75% |
1 |
F:hydrolase activity |
|
|
contig01837 |
---NA--- |
243 |
0 |
|
|
0 |
|
|
|
contig01838 |
mitochondrial ribosomal protein l22 |
1026 |
20 |
3.34E-50 |
87.75% |
5 |
C:mitochondrial ribosome; P:ribosome biogenesis; F:structural constituent of ribosome; C:large ribosomal subunit; P:translation |
EC:3.6.5.3 |
|
contig01839 |
---NA--- |
269 |
0 |
|
|
0 |
|
|
|
contig01840 |
aconitase mitochondrial |
935 |
20 |
1.38E-162 |
89.35% |
6 |
P:citrate metabolic process; F:iron ion binding; P:tricarboxylic acid cycle; F:4 iron, 4 sulfur cluster binding; F:aconitate hydratase activity; C:mitochondrion |
EC:4.2.1.3 |
|
contig01841 |
protein regulator of cytokinesis 1 |
864 |
20 |
2.40E-93 |
75.25% |
5 |
P:mitotic spindle elongation; F:protein binding; P:cytokinesis; C:nucleus; C:spindle microtubule |
|
|
contig01842 |
---NA--- |
264 |
0 |
|
|
0 |
|
|
|
contig01843 |
ubx domain containing 8 |
487 |
20 |
3.13E-72 |
97.25% |
2 |
F:protein binding; C:cytoplasm |
|
|
contig01844 |
---NA--- |
265 |
0 |
|
|
0 |
|
|
|
contig01845 |
hus1 checkpoint homolog ( pombe) |
299 |
20 |
1.08E-32 |
84.40% |
11 |
P:response to UV; P:G1/S transition checkpoint; F:protein serine/threonine kinase activity; P:negative regulation of DNA replication; P:double-strand break repair via homologous recombination; P:embryonic development; F:protein binding; P:DNA damage checkpoint; C:cytoplasm; C:nucleus; P:protein amino acid phosphorylation |
EC:2.7.11.0 |
|
contig01846 |
chaperonin containing subunit 3 |
719 |
20 |
4.30E-121 |
93.60% |
6 |
C:cytoplasm; P:protein folding; F:ATP binding; P:negative regulation of retinal cell programmed cell death; F:unfolded protein binding; P:embryonic eye morphogenesis |
|
|
contig01847 |
---NA--- |
260 |
0 |
|
|
0 |
|
|
|
contig01848 |
---NA--- |
339 |
0 |
|
|
0 |
|
|
|
contig01849 |
nuclear cap binding protein subunit 20kda |
542 |
20 |
4.99E-33 |
93.35% |
8 |
P:snRNA export from nucleus; P:RNA splicing; F:protein binding; P:mRNA transport; F:RNA cap binding; C:nucleus; P:positive regulation of RNA export from nucleus; F:nucleotide binding |
|
|
contig01850 |
mis12 homolog |
726 |
20 |
1.03E-69 |
64.90% |
2 |
P:cell cycle; C:chromosome, centromeric region |
|
|
contig01851 |
mitochondrial ribosomal protein l37 |
946 |
20 |
4.16E-105 |
73.05% |
4 |
F:translation regulator activity; C:mitochondrial ribosome; F:structural constituent of ribosome; P:translation |
EC:3.6.5.3 |
|
contig01852 |
peroxisome biogenesis factor 26 |
527 |
20 |
5.47E-63 |
67.75% |
5 |
P:protein import into peroxisome matrix; C:peroxisome; F:protein complex binding; C:membrane; F:protein C-terminus binding |
|
|
contig01853 |
---NA--- |
615 |
0 |
|
|
0 |
|
|
|
contig01854 |
---NA--- |
244 |
0 |
|
|
0 |
|
|
|
contig01855 |
proteasome maturation protein |
753 |
20 |
8.19E-65 |
90.65% |
4 |
P:immune response; C:cytosol; C:protein complex; C:nucleus |
|
|
contig01856 |
guanine nucleotide binding alpha transducing 3 |
1385 |
20 |
7.23E-145 |
67.20% |
5 |
C:heterotrimeric G-protein complex; F:GTP binding; P:sensory perception of taste; P:G-protein coupled receptor protein signaling pathway; F:GTPase activity |
EC:3.6.5.1; EC:3.6.5.2; EC:3.6.5.3; EC:3.6.5.4 |
|
contig01857 |
---NA--- |
259 |
0 |
|
|
0 |
|
|
|
contig01858 |
protein tyrosine phosphatase-like a domain containing 1 |
476 |
20 |
7.16E-53 |
82.05% |
4 |
P:JNK cascade; C:integral to membrane; P:I-kappaB kinase/NF-kappaB cascade; P:Rho protein signal transduction |
|
|
contig01859 |
5 -nucleotidase domain containing 2 |
398 |
20 |
1.67E-57 |
86.85% |
2 |
F:F; C:C |
|
|
contig01860 |
peptidoglycan- domain containing 2 |
367 |
20 |
6.46E-22 |
62.60% |
3 |
F:F; P:cell wall macromolecule catabolic process; C:C |
|
|
contig01861 |
n-myristoyltransferase 2 |
503 |
20 |
1.43E-43 |
95.20% |
4 |
C:cytoplasm; P:protein lipoylation; P:N-terminal peptidyl-glycine N-myristoylation; F:glycylpeptide N-tetradecanoyltransferase activity |
EC:2.3.1.97 |
|
contig01862 |
comm domain containing 2 |
443 |
20 |
7.87E-15 |
80.20% |
1 |
F:protein binding |
|
|
contig01863 |
nucleolar complex associated 3 homolog |
352 |
20 |
7.27E-29 |
91.65% |
3 |
C:nucleolus; P:fat cell differentiation; C:nuclear speck |
|
|
contig01864 |
---NA--- |
520 |
0 |
|
|
0 |
|
|
|
contig01865 |
---NA--- |
328 |
0 |
|
|
0 |
|
|
|
contig01866 |
---NA--- |
255 |
0 |
|
|
0 |
|
|
|
contig01867 |
imp (inosine monophosphate) dehydrogenase 2 |
537 |
20 |
1.63E-20 |
97.60% |
5 |
F:IMP dehydrogenase activity; P:GMP biosynthetic process; F:protein binding; F:potassium ion binding; P:lymphocyte proliferation |
EC:1.1.1.205 |
|
contig01868 |
replication factor c (activator 1) 3 |
418 |
20 |
1.16E-66 |
92.75% |
7 |
P:DNA replication; F:ATPase activity; F:DNA binding; C:DNA replication factor C complex; F:protein binding; F:ATP binding; C:nucleus |
|
|
contig01869 |
neural precursor cell developmentally down-regulated 1 |
661 |
4 |
4.82E-33 |
65.00% |
2 |
F:F; P:P |
|
|
contig01870 |
ubiquitin specific protease 4 |
394 |
20 |
4.14E-56 |
93.85% |
5 |
C:cytoplasm; P:ubiquitin-dependent protein catabolic process; F:ubiquitin thiolesterase activity; P:ubiquitin cycle; C:nucleus |
EC:3.1.2.15 |
|
contig01871 |
---NA--- |
243 |
0 |
|
|
0 |
|
|
|
contig01872 |
drebrin- isoform cra_b |
407 |
20 |
2.33E-27 |
97.80% |
14 |
C:ruffle; P:actin filament bundle assembly; P:barbed-end actin filament capping; C:dendrite; F:protein C-terminus binding; F:actin filament binding; F:identical protein binding; P:actin filament severing; P:immune response; C:cell cortex; P:endocytosis; C:lamellipodium; P:Rac protein signal transduction; C:postsynaptic density |
|
|
contig01873 |
---NA--- |
687 |
0 |
|
|
0 |
|
|
|
contig01874 |
---NA--- |
258 |
0 |
|
|
0 |
|
|
|
contig01875 |
heavy neurofilament protein |
1043 |
6 |
4.38E-05 |
40.33% |
0 |
|
|
|
contig01876 |
kinesin family member 23 |
785 |
20 |
2.66E-85 |
76.70% |
12 |
P:mitotic spindle elongation; P:microtubule-based movement; F:protein binding; P:mitosis; P:cytokinesis; P:embryonic cleavage; C:spindle; F:ATP binding; C:nucleus; C:kinesin complex; F:microtubule motor activity; C:microtubule |
|
|
contig01877 |
eukaryotic translation initiation factor subunit 10 |
1234 |
20 |
9.00E-19 |
49.80% |
9 |
C:eukaryotic translation initiation factor 3 complex; P:regulation of translational initiation; C:nucleus; C:cytoplasm; P:translation; F:protein binding; F:translation initiation factor activity; P:P; F:structural molecule activity |
|
|
contig01878 |
---NA--- |
283 |
0 |
|
|
0 |
|
|
|
contig01879 |
family with sequence similarity member b |
440 |
20 |
7.32E-58 |
89.40% |
0 |
|
|
|
contig01880 |
---NA--- |
276 |
0 |
|
|
0 |
|
|
|
contig01881 |
set bifurcated 2 |
808 |
20 |
2.61E-83 |
74.75% |
5 |
P:chromatin modification; F:DNA binding; F:histone-lysine N-methyltransferase activity; C:nucleus; F:zinc ion binding |
EC:2.1.1.43 |
|
contig01882 |
serine incorporator 1 |
377 |
20 |
7.29E-29 |
82.05% |
2 |
C:membrane; F:electron carrier activity |
|
|
contig01883 |
---NA--- |
860 |
0 |
|
|
0 |
|
|
|
contig01884 |
alpha3-fucosyltransferase [Takifugu rubripes] |
654 |
1 |
1.21E-04 |
91.00% |
7 |
P:protein amino acid glycosylation; F:fucosyltransferase activity; F:transferase activity; C:integral to membrane; C:membrane; C:Golgi apparatus; F:transferase activity, transferring glycosyl groups |
|
|
contig01885 |
chromosome 9 open reading frame 156 |
732 |
20 |
9.48E-87 |
85.95% |
1 |
F:hydrolase activity |
|
|
contig01886 |
exosome component 6 |
324 |
13 |
4.57E-15 |
76.54% |
6 |
F:RNA binding; C:cytoplasm; P:RNA processing; C:nucleus; C:exosome (RNase complex); F:exonuclease activity |
|
|
contig01887 |
upregulated during skeletal muscle growth 5 |
639 |
7 |
8.27E-19 |
69.71% |
4 |
C:mitochondrion; C:integral to membrane; C:membrane; C:mitochondrial inner membrane |
|
|
contig01888 |
---NA--- |
383 |
0 |
|
|
0 |
|
|
|
contig01889 |
argininosuccinate lyase |
323 |
20 |
9.17E-48 |
84.00% |
13 |
P:response to hypoxia; P:arginine catabolic process; P:liver development; F:argininosuccinate lyase activity; P:response to nutrient; P:arginine biosynthetic process via ornithine; P:urea cycle; P:response to peptide hormone stimulus; P:response to glucocorticoid stimulus; P:kidney development; C:cytoplasm; P:response to cAMP; P:argininosuccinate metabolic process |
EC:4.3.2.1 |
|
contig01890 |
14-3-3 protein beta alpha |
1501 |
20 |
7.19E-101 |
87.70% |
5 |
F:protein domain specific binding; F:monooxygenase activity; C:melanosome; P:protein targeting; C:perinuclear region of cytoplasm |
|
|
contig01891 |
---NA--- |
263 |
0 |
|
|
0 |
|
|
|
contig01892 |
unnamed protein product [Tetraodon nigroviridis] |
1426 |
4 |
1.57E-25 |
71.75% |
0 |
|
|
|
contig01893 |
flavohemoprotein b5 b5r |
318 |
20 |
4.15E-32 |
76.15% |
7 |
C:cytoplasm; F:cytochrome-b5 reductase activity; P:heme biosynthetic process; P:cellular iron ion homeostasis; F:iron ion binding; F:heme binding; P:iron ion transport |
EC:1.6.2.2 |
|
contig01894 |
cdc5 cell division cycle 5-like ( pombe) |
1139 |
20 |
1.08E-108 |
83.30% |
12 |
F:RNA binding; P:cell cycle; P:regulation of transcription, DNA-dependent; C:nuclear speck; P:RNA splicing; P:cell division; F:DNA binding; P:protein targeting; C:spliceosomal complex; F:protein domain specific binding; P:mRNA processing; C:cytoplasm |
|
|
contig01895 |
bcs1-like |
256 |
20 |
5.24E-43 |
90.35% |
7 |
P:protein complex assembly; C:mitochondrial respiratory chain complex III; P:sensory perception of sound; C:membrane attack complex; F:ATP binding; F:nucleoside-triphosphatase activity; P:energy derivation by oxidation of organic compounds |
EC:3.6.1.15 |
|
contig01896 |
---NA--- |
263 |
0 |
|
|
0 |
|
|
|
contig01897 |
---NA--- |
384 |
0 |
|
|
0 |
|
|
|
contig01898 |
---NA--- |
165 |
0 |
|
|
0 |
|
|
|
contig01899 |
---NA--- |
1088 |
0 |
|
|
0 |
|
|
|
contig01900 |
gdp-mannose pyrophosphorylase a |
245 |
20 |
3.56E-36 |
84.10% |
3 |
P:biosynthetic process; F:nucleotidyltransferase activity; F:acyltransferase activity |
EC:2.7.7.0 |
|
100 Rows returned.